Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BT524 in Congenital Fibrinogen Deficiency
NCT02065882Phase 3Completed
- Sponsor
- Biotest AG
- Start
- Mar 2013
- Primary completion
- May 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 3 trial of Fibrinogen human in congenital fibrinogen deficiency (CFD), sponsored by Biotest AG. Started Mar 2013; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
congenital fibrinogen deficiency (CFD)
Beyond the preview
Go deeper on NCT02065882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02065882.